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Abstract—Wireless all-analog biosensor design for concurrent
microfluidic and physiological signal monitoring is presented in
this work. The key component is an all-analog circuit capable
of compressing two analog sources into one analog signal by
Analog Joint Source-Channel Coding (AJSCC). Two circuit
designs are discussed, including the stacked-Voltage Controlled
Voltage Source (VCVS) design with the fixed number of levels,
and an improved design, which supports a flexible number of
AJSCC levels. Experimental results are presented on the wireless
biosensor prototype, composed of Printed Circuit Board (PCB)
realizations of the stacked-VCVS design. Furthermore, circuit
simulation and wireless link simulation results are presented
on the improved design. Results indicate that the proposed
wireless biosensor is well suited for sensing two biological signals
simultaneously with high accuracy, and can be applied to a wide
variety of low-power and low-cost wireless continuous health
monitoring applications.
Index Terms—Wireless Sensors, Microfluidic Sensing, Physiolog-
ical Signal Sensing, Analog Compression.
I. INTRODUCTION
Background: The design of wireless biosensors is essential
to the realization of wireless health monitoring solutions [2].
Wireless monitoring of physiological signals brings the advan-
tages of portability [3], wearability [4], continuous measure-
ments [5], and improved point-of-care to patient in comparison
with wired counterparts. Furthermore, microfluidic biosensors
have emerged as powerful tools for wearable biomarkers
monitoring, including electrical impedance detection [6], Giant
Magnetoresistance (GMR) sensing [7], and electrochemical
detection [8], [9]. Microfluidic sensing can enable wearable
sensors that are minimally invasive due to the minute sam-
ple volumes required for accurate sensing, thus promoting
personalized health monitoring through continuous quantifi-
cation of biomarkers. The detection of various biomolecules
in blood samples using impedance-based biodetection has
been demonstrated in previous works [10], which shows the
potential to realize truly miniaturized wearable diagnostic
platforms. Among the microfluidic sensors, impedance-based
sensors typically integrate electrodes in microfluidic channels
and monitor changes in impedance as particles flow over the
electrodes. This class of sensors has been shown to be well
suited for detecting biomarkers with high sensitivity [11], [12].
Impedance-based sensors can be made portable with miniatur-
ized analog front-end circuitry such as lock-in-amplifiers [13],
and wireless transmitters. Functionalization of microfluidic
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channels in impedance cytometers with different types of
antibodies and enzymes can enable biomarkers detection with
high specificity.
There are various scenarios where a network of wireless body
sensors monitoring both physiological signals and molecular
biomarkers concentrations are beneficial to patient care. One
medical scenario is monitoring hospitalized patients with
cardiovascular disease. There is a vast body of literature
regarding the benefits of monitoring patients with cardiovas-
cular disease continuously. Kario et al. [14] demonstrated
the usage of wireless sensors to monitor the physiological
signals of blood pressure and the environmental parameters for
patients with cardiovascular disease. Hu et al. [15] presented
a microfluidic-based portable device to improve point-of-care
monitoring of cardiovascular disease patients. We envision
wireless wearable sensors potentially replacing wired tags
used to monitor physiological signals including Electrocar-
diogram (ECG), heart rate, respiratory rate, blood pressure,
temperature and blood oxygen levels by electrical or optical
sensors, providing continuous wireless monitoring of these
vital signs. In addition, various blood biomarkers reflecting
the state of the cardiovascular and endocrine system, can also
be monitored in these wearable sensor networks. Potential
cardiac markers of interest include levels of cardiac Troponin,
BNP, creatinine, C-reactive protein (CRP), and also complete
blood cell counts. The true power of both physiological
and biomarker measurements can be realized when both are
combined together and the correlations between the two data
types are better understood. In this work, we present a wireless
biosensor design that can measure physiological signal and
molecular biomarkers concurrently. A network of body sensors
monitoring various physiological parameters simultaneously
with biomarkers monitoring in blood, sweat, and exhaled
breath condensate can greatly improve our understanding of
disease pathogenesis.
The circuit design of the biosensor forms the foundation of this
type of hybrid wearable wireless biosensing platform. Existing
wireless biosensor designs rely on digital circuits that have
high complexity and are power inefficient. These limitations
hinder the much needed features of large-scale deployment
and battery-less monitoring. In this work, we are bridging the
technological gap between hybrid sensor design and analog
circuitry, by introducing a particular type of analog signal
compression circuit that is aimed at compressing microfluidic
and physiological signals, without the need of digital circuits.
This work ultimately eliminates the operations of conversions
between digital and analog signals, therefore significantly
improving the power efficiency of biosensor circuits. More-
over, signal recovery performance of the proposed circuit is
guaranteed for target applications.
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Existing Work: A sensing system was demonstrated [16]
where sweat-lactate concentration is measured electrochem-
ically with a concurrent ECG measurement. Here, the sweat-
lactate concentration and ECG signals are first passed to an
Analog-to-Digital Converter (ADC) for processing by a micro-
controller, and then are wirelessly transmitted via Bluetooth
module. Luhmann et al. [17] demonstrated a wireless sensor
that simultaneously measures the EEG and neurophysiological
signal using digital transmission of the data via Bluetooth.
Abrar et al. [18] presented a wireless sensor in which the sweat
lactate is measured and the sensing signal is sampled with an
ADC, processed by a microprocessor, and then transmitted by
a digital Near-Field Communication (NFC) wireless module.
Nemiroski et al. [19] designed a digital mobile system for the
transmission of electrochemical detection data. In all these
systems, the major power consumption is due to the digital
conversion by the ADCs and subsequent processing by the
microcontrollers, which limits the battery life of the devices
and the practicality of the system. Our previous work [20]
proposed an analog compression circuit for two signals, and
introduces the technique in a generalizable context. However,
it was limited to wireless circuits only and did not include
biosensors for biomarker detection, which involves measuring
signals that are rapidly changing, thus the challenges involved
with the current manuscript are of a different nature, and
require significant testing and integration of a new type of
readout circuit, namely the lock-in-amplifier. In the current
manuscript, we are integrating two sensors that are of a
different class and entirely different nature, a physiological
signal sensor which is more of a physical measurement, and a
microfluidic impedance sensor, which falls under the class of
biological/chemical measurements. In this manuscript, we, for
the first time ever, show the potential for using Analog Signal
compression for signals obtained from these two different
classes of signals. For this purpose, we performed novel
experiments to achieve simultaneous microfluidic impedance
cytometry and physiological signal sensing. We also per-
formed systematic wireless link level simulations to evaluate
the signal recovery performance of the proposed wireless
biosensing system under various indoor and outdoor signal
propagation conditions. This work shows the promise of our
vision for a compression scheme that would work with a
network of body sensors that are continuously obtaining both
physical and biochemical data.
Our Contributions: In this study, we mimic the measure-
ment of blood cells on a microfluidic impedance cytometer
(microfluidic channel with 30 µm width and 20 µm height)
using 7.8 µm diameter beads in saline buffer. The physiolog-
ical signals are the electrical Galvanic Skin Response (GSR)
measurement of skin conductance via Shimmer sensors with
a maximum value of 2.6 Ω−1. This work is distinct from
prior works in that the detected physiological and biomarker
analog signals are directly compressed in the analog domain
by an analog circuit, and are modulated and transmitted via
analog Radio Frequency (RF) communication chain. There are
no power-hungry digital circuits such as ADCs, Digital-to-
Analog Converters (DACs) or microprocessors in the sensor,
which enables the sensor to run on power gathered from
energy-harvesting techniques such as human motion. The
all-analog circuit performing the compression is based on
an encoding technique termed Analog Joint Source Channel
Coding (AJSCC) [21]–[23], where a digital Cluster Head (CH)
receiver performs the AJSCC decoding to recover the source
signals. The major contributions of this work include:
• An all-analog wireless biosensor design is presented,
consisting of concurrent microfluidic impedance sensing
as well as physiological signal sensing and subsequent
signal compression by an AJSCC circuit.
• Two circuit designs of the AJSCC encoding are
presented—the first supporting a fixed and small number
of AJSCC levels, and the second supporting a flexible
and larger number of levels (within a certain range).
• The presented biosensor system is validated via hardware
experiments using the first design (Design 1), and by
circuit and wireless link simulations for the second design
(Design 2).
Article Outline: In Sect. II, our wireless biosensor design
for dual measurements is presented including its equivalent
circuit model, microfluidic device fabrication procedure, and
improved design for AJSCC encoding circuitry. In Sect. III,
hardware experimental results for Design 1, circuit simulation
and wireless link simulation results for Design 2 are presented.
Finally, in Sect. IV, conclusions are drawn.
II. PROPOSED WIRELESS BIOSENSOR PROTOTYPE
We first present the system design of the wireless biosen-
sor prototype including the equivalent circuit model of the
microfluidic channel, the prototype system setup, and the
microfluidic device fabrication procedure in Sect. II-A. Then,
an improved circuit design of the AJSCC encoding, Design 2,
is presented in Sect. II-B.
A. Wireless Sensor System
The wireless sensor circuit depicted in Fig. 1, is composed
of the microfluidic sensing circuit, and the all-analog signal
compression and wireless transmission circuits. The microflu-
idic system adopts impedance-based particle-concentration
measurement. The equivalent circuit of the impedance-based
microfluidic system in this study has been used for prior
work also in [24]. The microfluidic device consists of the
microfluidic PDMS (polydimethylsiloxane) channel on a pair
of co-planar electrodes. The equivalent circuit inside the
microfluidic channel and the sensor can be modeled by two
double-layer capacitors Cdl, one resistor R, and one capacitor
Ccell in parallel as shown in Fig. 1. When a molecule passes
by, the resistor will have a change in resistance ∆R, which
will result in a change in signal detection. The impedance
measurement is excited with a cosine wave with frequency
f0. The resistance change ∆R and the voltage change will be
detected and amplified by the lock-in amplifier with feedback
resistance Rf . The signal is then passed to a mixer with
frequency f0 and then through a low-pass filter. For this
equivalent circuit model, molecules passing the electrode will
cause impedance variation, and molecules of different sizes
will have different impedance variation in the output pulse
response. The sensitivity depends on a number of conditions,
including the dimensions of the microfluidic channel, the
choice of the excitation frequency, the noise level of the
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Fig. 1: All-analog circuit diagram with microfluidic and physiological sensing signal compressed by Analog Joint Source Channel Coding (AJSCC) circuit [21]
with Frequency Division Multiple Access (FDMA) to multiplex a large number of sensors. The microfluidic equivalent circuit and the lock-in amplifier front-
end circuit are depicted. The AJSCC circuit realizes fixed number of levels with stacked VCVS design (Design 1). Note that, the time-domain waveforms of
microfluidic signal x1, physiological signal x2 and the AJSCC-encoded signal are depicted in Fig. 2a.
front-end circuit, and the detection algorithm. An optimized
impedance-based microfluidic system considering all of these
parameters can detect sub-µm particles. In our previous work,
we have shown that the microfluidic sensor can detect micron-
sized beads variations within 2 µm in diameter (adequate for
cells). In other studies, researchers have demonstrated the
ability to detect particles at the nano-scale [25], [26].
System Setup: To demonstrate a proof-of-concept design,
we quantify the microbeads in the microfluidic channel to
mimic the blood cell quantification process. In this work,
the sensor quantifies the number of beads, which is similar
to how the number of cells in a blood sample would be
quantified. The detection of real cells in a complex biological
sample like blood is beyond the scope of this work. The
cells are loaded into the micro-channel and directed to the
microfluidic sensing region. The particles passing the electrode
will produce pulses in the voltage output as described in [10],
[24]. The microfluidic signal is generated by micron-sized
beads passing through the co-planar electrode pair in the
microfluidic channel with a width of 30 µm and a height of
20 µm. The electrode dimension is 20 µm width and 200 nm
length, with a spacing of 25 µm between the electrode pair. The
effective length of the electrodes is 30 µm, which is the amount
overlapping with the microfluidic channel and is exposed to the
electrolyte. The signal is excited with cosine-ware frequency
f0 of 500 kHz. The flow rate is 0.1 µL/min. The bead size is
7.8 µm. A sequence of pulses is generated with beads flowing
over the electrode pair and the signal is recovered using the
lock-in amplifier analog circuit [13].
Microfluidic Sensor Fabrication: The microfluidic
impedance cytometer is fabricated using soft lithography [27].
The sensor and the microchannel are fabricated individually
before incorporating into the microfluidic device. Photomasks
for the lithography processes are designed using AutoCAD.
The photomasks are fabricated by Advance Reproductions
Corp. (North Andover, MA).
(i) Microfluidic Channel: The microchannel is constructed
using PDMS and standard molding techniques [27]. The
master mold is fabricated with SU-8 photoresist. To fabricate
the microchannel, PDMS solution is poured onto the mold
and cured at 80 ◦C for an hour. After curing, the PDMS is
peeled off from the mold to create the microfluidic channel.
(ii) Microelectrode: The microelectrodes are fabricated on the
glass substrate using standard photolithography. Photoresist
AZ5214 is spin coated on the substrate and exposed to UV
light under the the microelectrode photomask. The coated
glass wafer is then developed in AZ5214 developer. The
photoresist exposed to UV light would be washed away
creating the pattern of the microelectrodes. A thin layer
of chromium and gold (50 A˚ and 200 nm respectively) are
deposited on the wafer using using electron beam evaporation.
(iii) Microfluidic Device: A PDMS chip embedded with a
microchannel is covalently bonded to the glass wafer with
microelectrodes to create the microfluidic device. The surfaces
of glass and PDMS are exposed to oxygen plasma to generate
thin layers of silanol terminations (SiOH). When brought in
contact with the oxidized glass surface, the silanol terminated
layers come together to create the conformal Si-O-Si covalent
bonds between the polymer and glass [28]. The oxygen
plasma also makes the PDMS surface hydrophilic [29]. This
allows for capillary flow of fluid/cells through the impedance
cytometer without the need for external syringe pumps.
Key Sensor Circuit Design 1: The circuit design (Design 1)
of the AJSCC encoding is depicted in Fig. 1. In the all-analog
realization of AJSCC circuit [21], the microfluidic sensing
signal x1 controls the output of Voltage Controlled Voltage
Sources (VCVS). Note that there are two types of VCVS,
type-1 and type-2. For type-1 VCVS, the output voltage of
VCVS increases linearly with the increment of the controlling
voltage x1, which corresponds to the odd-numbered levels in
AJSCC; and for type-2 VCVS, the output voltage of VCVS
decreases linearly with the increment of the controlling voltage
x1, which corresponds to the even-numbered levels in AJSCC.
Each VCVS is switched among saturation voltage VR, the
linear voltage output corresponding to x1, and ground. The
physiological signal x2 is the control signal of the VCVS
composed of L stages. With larger physiological signal, there
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will be more stages being activated. For example, if there are
M stages being activated, the M -th stage will be controlled
by the signal coming from the impedance cytometer x1 to
produce a continuous varying output voltage, and the 1-st to
the M−1-th stages will output the maximum voltage VR. The
other higher L−M stages produce zero grounded outputs. The
voltages of all the stages are summed together by an analog
voltage adder to produce the desired AJSCC encoded voltage.
The signal is then passed to RFIC and the antenna. Because
of the stacking of multiple VCVS blocks corresponding to
different stages, we call this “Stacked VCVS” design.
The power consumption of our analog AJSCC board (with
“Stacked VCVS” design) without radio power is estimated
to be 130 µW for a discrete-component realization as fol-
lows [21]. Our circuit in total (5 and a half stages/11 levels)
consists of 16 OpAmps, 17 Comparators, and 11 Multiplex-
ers, where OpAmps are clearly the major contributors to
the overall power consumption. There are many low-power
designs proposed for these components. For example, a low-
power OpAmp [30] consuming about 8 µW, a compara-
tor [31] consuming about 12.7 nW, and an analog multiplexer
(ADG704) consuming about 10 nW can be used for our
circuit resulting in a power consumption of ≈ 130µW. We
believe this number can be even lower (to less than 50 µW)
if an Integrated Circuit (IC) design is adopted, because of
the following reasons: (i) a design using discrete components
for different functionalities of the circuit uses extra hardware
as inter-component optimization is not feasible as in an IC
implementation; (ii) in general, the larger the area of the chip,
the higher the power consumption [32], which is due to the
use of a larger substrate or a combination of several smaller
substrates (corresponding to different discrete components).
On the other hand, in an IC, all the functionalities are designed
on top of a single tiny substrate resulting in much lower
area and, hence, a much lower power consumption; (iii) using
IC design allows the use of latest nm-Si (nanometer-Silicon)
technology (e.g., 10 nm currently or 5 nm in near future) for
the fabrication of the chip, which again results in lower power
consumption as the area is reduced owing to lower dimensions
of the transistors’ channel. We expect these reasons will help
reduce the power consumption by more than half resulting
in < 50 µW power consumption. On the other hand, for
state-of-the-art wireless digital sensors (e.g., [33], [34]) the
consumption is at least 1-2 mW in active mode. A detailed
power comparison of our AJSCC system with existing wireless
sensors can be found in [22]. The fabrication cost can also be
kept lower than the digital counterpart by leveraging mass IC
production.
B. Key Sensor Circuit Design 2
There is a scope of further reduction in power consumption
and circuit complexity (which translates to cost) of the AJSCC
circuit in Design 1 (Sect. II-A). As can be noticed, Design 1
adopts a fixed number of AJSCC levels which needs to
be decided before the fabrication of the chip, making the
sensing resolution in x2 fixed once the chip is fabricated.
On the other hand, it may be necessary to vary the sensing
resolution based on the application. For example, until certain
symptoms are detected a lower resolution in x2 (i.e., higher ∆)
can be adopted and the resolution can be increased if some
preliminary symptoms are detected. Secondly, in Design 1,
the hardware corresponding to each level/stage is duplicated
as many times as the number of AJSCC levels. This is an
inefficient approach, both in terms of power consumption as
well as complexity/cost as the hardware in each level can be
reused instead of being duplicated. Finally, since having a large
number of AJSCC levels is tedious with this approach (since it
does not scale well with the number of levels), it leads to more
quantization in x2 (as can be observed in the experimental
section, Sect. III-A).
In order to address the above limitations of Design 1, we
present a novel Design 2 where the number of AJSCC levels
can be user defined within a certain range (even after the
fabrication of the chip) as well as has much lower power
consumption and circuit complexity compared to Design 1
(especially for number of levels greater than 16). The improved
sensor circuit design (Design 2) is given in our previous work
[20]. To connect this circuit with biosensing, the physiological
signal x2 is first divided by the tunable spacing between
levels, ∆ using a multi-stage analog divider to produce the
quotient of the division. The quotient is fed to two blocks—
an analog multiplier and an odd/even detector block which
detects whether the quotient is odd or even. On the other hand,
the microfluidic signal, x1 is fed to both type-1 VCVS and
type-2 VCVS blocks to produce respective type-1 or type-2
outputs which are proportional and inversely proportional to
x1 respectively. Whether to use type-1 output or type-2 output
depends on which numbered level the mapped AJSCC point is
(where the number is the quotient of the division). If it falls on
an even level (0, 2, ...), type-1 output needs to be considered
and vice-versa. Hence, the odd/even detector (of quotient) can
control which output is considered via an analog switch. Then
the quotient multiplied by the level saturation voltage, VR is
added to the switch output to produce the final AJSCC encoded
voltage.
We have implemented the entire encoding circuit of Design 2,
i.e., from inputs x1 and x2 till the output of adder using
Spice [20], where, the multi-stage analog divider and odd/even
detector block combined are implemented as a single circuit.
For further details on the implementation, comparison with
Design 1 in terms of complexity and power consumption,
maximum and minimum variation in ∆ (in other words, the
number of levels, L) supported by the circuit, please refer
to our previous work [20]. The choice of the parameter
L, depends on the distribution of the source signals, the
transceiver design, and the wireless channel conditions. To
find the optimal parameter L, we need to evaluate the wireless
communication system performance under different channel
conditions, which has been done in Sect. III-B. From these
results, we are able to make the judgment on the optimal L
for a given biosensing application.
III. PERFORMANCE EVALUATION
In this section, we present the validation results of the pro-
posed biosensing platform. Specifically, we present the exper-
imental results of our wireless biosensor using the AJSCC
Printed Circuit Board (PCB) implementation of Design 1 in
Sect. III-A. Then, the circuit simulation results of Design 2 and
wireless link simulation results of the sensor with Design 2 to
find the optimal parameters are presented in Sect. III-B.
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Fig. 2: (a) Microfluidic (cytometry), physiological (GSR), and AJSCC-encoded voltage signal at the transmitter. With respect to Fig. 1, x1 is the microfluidic
(cytometry) signal, x2 is the physiological (GSR) and the output of the AJSCC encoding circuits is the AJSCC-encoded voltage. (b) Decoded microfluidic
(cytometry) signal at the digital CH receiver—before (top) and after (bottom) filtering; (c) Decoded physiological (GSR) signal at the CH—before (top) and
after (bottom) filtering. The bead site is 7.8 µm and the flow rate is 0.1 µL/min. The microfluidic channel has width of 30 µm and height of 20 µm. The
GSR signal (measured as skin conductance) is measured with the Shimmer GSR sensor with maximum value of 2.6 MΩ−1.
Fig. 3: The right-hand side shows the cytometry system, which generates the
impedance cytometry signal. Prior collected GSR data is used to generate an
analog signal using Labview on a computer and NI DAQ system (left top).
Both these analog signals are fed to the AJSCC board (left bottom), which
does the AJSCC encoding and transmits wirelessly to a digital CH receiver
(not shown). The impedance pulses are generated by the impedance cytometer,
and the GSR signals are generated by the NI DAQ device. The AJSCC board
performs data compression in the analog domain, and transmits the signal
wirelessly.
A. Experimental Results with Design 1
The experiment is designed as a proof of concept to verify the
functionalities of the key sensor circuit Design 1 (11 AJSCC
levels using stacked VCVS design) at the transmitter side as
well as at the receiver to recover the two compressed signals.
Experimental Setup: The test is performed in an indoor
environment with a carrier frequency of 2.4 GHz and an omni-
directional antenna. The distance between the transmitter and
receiver is about 5 meters. The transmitter system is shown
in Fig. 3. The physiological signal is chosen to be a GSR
signal connected via Bluetooth using Shimmer sensors, and
the signal is regenerated using NI LabView/DAQ system. Both
of these signals are fed to the circuit board developed in [21]
to perform the sensor signal encoding in the analog domain.
Transmitter AJSCC Encoding: The original microfluidic
signal, physiological signal, and the AJSCC encoded signal
in the transmitter are depicted in Fig. 2a as captured using NI
DAQ hardware and LabView software.
We can observe that AJSCC encoding compresses the two
signals into a single one such that the microfluidic signal
is riding on top of the physiological signal. We note that
our AJSCC sensor board introduces a quantization error in
the physiological signal since it has only 11 levels in the y-
dimension, as seen in Fig. 2a where the physiological signal
portion in the AJSCC encoded signal has been quantized. This
AJSCC encoded signal is frequency modulated, upconverted,
and then transmitted using Commercial Off The Shelf (COTS)
RFIC chip.
Receiver Decoding: At the receiver, the signal is down-
converted (to baseband) and then frequency demodulated to
recover the AJSCC encoded signal. The demodulation process
is as follows. The baseband signal is captured into LabView
using an NI DAQ device. Then the signal is firstly sampled
with a sampling rate fs, then the frequency of the signal
is detected by an Fast Fourier Transform (FFT)-based fre-
quency detector with Ns samples per FFT. At the receiver,
the parameter Ns is chosen as 5, 000 and sampling rate fs
is set to 500 kHz, which is the maximum supported by
the DAQ device. The AJSCC-encoded signal is recovered
from the frequency values using simple linear mapping (as
done in the transmitter board). The AJSCC-encoded voltage
is then decoded to individual physiological and microfluidic
signals using simple modulo arithmetic [21]. The decoded
microfluidic signal in LabView is shown in Fig. 2b (top). It
can be observed that the peaks of the signal are recovered.
The error at the bottom of the signal is due to the bias in the
AJSCC stage mapping. The decoded physiological signal is
shown in Fig. 2c (top). The quantization effect of the recovered
physiological signal is due to the fact that in the transmitter
board only 11 stages are designed for the AJSCC mapping.
The error floor at the bottom of the microfluidic signal is
removed using a thresholding filter, where the threshold value
is set just above the error floor level. The unwanted spikes
in the physiological signal are smoothed using a 200-th order
median filter. The bottom portions of Figs. 2b and 2c show
the results after filtering.
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Fig. 4: AJSCC-encoded output of 16-level analog divider circuit with varying
x2 and x1 = 2.5 V and VREF = 3 V by LTSpice circuit simulation.
Scaling of physiological and impedance cytometer values is
done as follows: physiological being the conductance mea-
surements have the range in 100’s of kΩ−1 below 2.6MΩ−1,
which is not suitable value to be fed to hardware, hence we
linearly scaled the physiological values to a range from 1 to
3 V. On the other hand, even though microfluidic values are
within acceptable voltage ranges (0− 2 V), their contribution
reduces significantly in the AJSCC encoded signal due to 1 : 5
Voltage Controlled Voltage Source (VCVS) mapping in the
AJSCC encoding process [21]. Hence we had to upscale the
microfluidic signal to 0−10 V to make the microfluidic signal
and its peaks apparent in the AJSCC encoded signal. In the
experiments, the NI DAQ device was sampling the received
baseband signal at 500 kHz; however, the NI LabView was
not able to process the data at the same rate. Hence, we
collected the samples alone in the LabView (without further
processing) and then processed the samples in MATLAB for
frequency detection and AJSCC decoding. This also gave us
the opportunity to vary the window size Ns (and find the best
value) for frequency detection: a small window means fewer
samples for frequency estimation resulting in wrong frequency
values; on the other hand, a large window results in loss of
sampling accuracy (as we get averaged values instead of actual
values). After trying different values, we found that Ns=5, 000
gives the best results in that it matches closely the original
physiological and microfluidic signals.
B. Simulations of Design 2
In this subsection, we first briefly present the simulation
results of the improved AJSCC encoding circuit (Design 2,
Sect. II-B). Then the proposed wireless biosensor system
Design 2 that allows a large number of AJSCC levels is
evaluated in terms of the wireless channel conditions via
wireless link simulations.
Improved AJSCC Circuit (Design 2): Fig. 4 shows LTSpice
simulation output of the improved AJSCC circuit’s output
voltage (AJSCC encoded voltage) while varying x2 and fixing
x1 at 2.5 V so that the mapped point will always be at
the center of each level. The figure shows all the 16 levels
possible with k = 4 and matches the expectations of the
circuit in that—we can notice a discretization in the AJSCC
encoded voltage, xAJSCC owing to the discretization of x2
by the AJSCC encoding circuit. However, the amount of
discretization depends on the number of AJSCC levels and
Design 2 enables the realization of a large number of levels
easily as compared to Design 1 (the result shown here is
specifically for 16 levels). We describe the setup used for
wireless link simulations of our wireless biosensor system with
the flexible number of AJSCC levels (i.e., adopting Design 2).
Wireless Link Simulation Setup: The same cytometry and
GSR data used in the hardware experiments (Sect. III-A) is
adopted in the wireless link simulator for evaluating the system
performance. The cytometry and GSR data both have sample
spacing of 1 ms. The AJSCC encoder in the simulator has
the same voltage range for x1 and x2 as the hardware PCB
board, i.e., the x1 has a maximum of 2.25 V, and x2 has
a maximum of 3.0 V. The first step is to adjust the range
of input signals, x1, x2 to the AJSCC encoder. This is done
with a linear scaling of the input signals to the input range
of AJSCC encoder. We have also implemented the frequency
modulation adopted in the hardware board in the transmitter
of wireless link simulator. In the receiver, the sampled data is
sent to the FFT block for peak detection and signal recovery.
Two sets of sampling rate and FFT sizes are adopted in the
simulation. The first set is the same set of parameters used
in the hardware experiment–500 kHz sampling rate and FFT
size of 5000. However, this set of parameters will need a
time duration of 10ms to collect the data for producing one
sample of the source signal. The 500 kHz sampling rate in
the hardware experiment is due to the limitation of sampling
rate in the NI DAQ device adopted in the experiment. In the
simulation, we are able to evaluate at a much higher sampling
rate for real-time sensing and processing of the source signal.
The second set of parameters is motivated from this objective.
This set of parameters is designed to improve the previous
time duration to 1 ms. The sampling rate is 8.192 MHz,
and the FFT size is 8192. The frequency-modulated signal
is mapped to frequency up to 4 MHz. In this simulation, the
receiver is able to decode the transmitted signal in real time
corresponding to the software-based design of an improved
digital receiver.
In the receiver, the analog signal is firstly downconverted to
baseband frequency and then sampled using an ADC. The
digital signal is then passed to the FFT block for generating
the frequency-domain response. Peak detection is subsequently
performed to find the frequency-modulated signal to recover
the AJSCC-encoded signal. The AJSCC decoding is then
performed by reverse mapping on the AJSCC curve to recover
the two original mapped source signals. On the choice of the
sampling rate, we have evaluated two systems with sampling
rates of 500 kHz and 8.192 MHz to illustrate the difference
in the performance. We can observe that the sampling rate
of 8.192 MHz achieves better Mean Square Error (MSE)
performance compared to a sampling rate of 500 kHz, under
the same simulation assumptions.
The channel modeling is critical in the evaluation of wireless
system link-level performance [35], [36]. Four types of wire-
less channels are realized in the simulator: i) Additive White
Gaussian Noise (AWGN) channel; ii) Flat fading channel with
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Fig. 5: Cumulative Distribution Function (CDF) of cytometry peak values at
source, at the AJSCC decoding output in receiver for AWGN channel, flat
fading channel, indoor channel with 5 Hz Doppler, and outdoor channel with
20 Hz Doppler, by wireless link simulation.
single-tap and Rayleigh fading, for modeling isotropic scatter-
ing around the receiver. There is no Doppler in these channel
models; iii) Indoor multipath fading channel with Doppler.
The channel is named JTC Indoor Residential A. JTC, which
stands for Joint Technical Committee, is the name of the
multipath profile channel models [37]. This channel is almost
flat in our system and simulation setup; iv) Outdoor multipath
fading channel with Doppler 20 Hz. The channel model is
named JTC Outdoor Residential Areas–Low antenna A. The
Doppler spread is assumed as 20 Hz. The reason to choose
these channel models is that our hardware experimental system
is built with 2.4 GHz radios and works in an environment
similar to Wireless Local Area Network (WLAN) system, for
which JTC channel models have been designed. A parameter
named Channel Signal-to-Noise Ratio (CSNR) is defined for
evaluating the effect of noise. It is defined as the ratio of
channel gain with signal power, to the noise variance in dB.
Cytometry Pulse Peaks at Source and Receiver: The
cytometry and GSR source signals are inputs to the AJSCC
encoder in the simulator. Fig. 5 plots Cumulative Distribution
Function (CDF) of pulse peak values of the cytometry signal
for the following cases–(i) at source; (ii) at the receiver after
AJSCC decoding for AWGN channel and flat fading channel.
The CSNR of the AWGN channel and flat fading channel
are all 0 dB; (iii) at the receiver after AJSCC decoding for
indoor channel with 5 Hz Doppler and outdoor channel with
20 Hz Doppler. The CSNR of the indoor and outdoor channels
are all 10 dB for these distributions. The digital receivers of
all channel conditions evaluated adopt 8.192 MHz sampling
frequency with 8192 FFT size. To quantify the similarity of
the distributions between the source and received peak values,
a statistical test is necessary. The received peak data can be
evaluated by the Two-sample Kolmogorov-Smirnov (K-S) test.
The K-S test is run on the two sets of data, the source cy-
tometry peak values, and the received cytometry peak values.
The digital receivers evaluated have 8.192 MHz sampling
frequency with 8192 FFT size for all channel conditions. The
results of p-values at different AJSCC levels and the K-S
test results are summarized in Table I. The AWGN and flat-
TABLE I: P-values of Kolmogorov-Smirnov (K-S) hypothesis test results for
number of AJSCC parallel lines equaling 30 and 50. The null hypothesis of
K-S test is that, the peak distributions at source and receiver are from the
same distribution. The K-S test is performed on 5% significance level.
Case # Channel Type No.
AJSCC
Lines
P-value K-S
Test
(5%)
1 AWGN 30 0.3783 0
2 AWGN 50 0.3065 0
3 Flat fading, no Doppler 30 0.2459 0
4 Flat fading, no Doppler 50 0.2534 0
5 Indoor, 5 Hz Doppler 30 0.3974 0
6 Indoor, 5 Hz Doppler 50 0.2448 0
7 Outdoor, 20 Hz Doppler 30 0.2086 0
8 Outdoor, 20 Hz Doppler 50 0.1898 0
fading channels have 0 dB CSNR, and the indoor and outdoor
channels have 10 dB CSNR. From the table, we can observe
that the p-values for all the channel conditions are not small,
which indicates that there is no statistical significance to the
difference between the distributions at transmitter and receiver
for all the channel conditions evaluated.
Signal Recovery Performance of AJSCC: MSE performance
of the AJSCC is now presented for the proposed system with
cytometry and GSR data as source signals. AWGN, flat fading,
indoor, and outdoor JTC channels are considered.
Performance under AWGN and Flat Fading Channels: The
simulation results of MSE vs. the number of parallel lines
in AWGN channel are depicted in Figs. 6a, 6b. The channel
has CSNR equaling to 0 dB. Two types of digital receivers
are evaluated—8.192 MHz sampling rate with 8192 FFT size
(Fig. 6a) and 500 kHz sampling rate with 5000 FFT size
(Fig. 6b). It can be observed that the cytometry recovery MSE
performance for 8.192 MHz sampling rate is much lower for a
number of AJSCC lines less than or equal to 20 compared with
500 kHz sampling rate. In addition to real-time processing,
this MSE advantage is the second reason that the 8.192 MHz
sampling-rate system is preferred over the 500 kHz sampling-
rate system. The result of MSE vs. the number of parallel lines
in AJSCC for flat-fading channel with zero Doppler is depicted
in Fig. 6c. The results of flat-fading channel are on 8.192 MHz
sampling rate system and CSNR equaling to 0 dB. We observe
a trade-off between the MSE of cytometry data and the GSR
signal in all plots in Fig. 6. Since the frequency bandwidth
allocated is fixed, with increasing number of AJSCC levels,
the frequency resource allocated per level is reduced, therefore
the MSE of cytometry data increases with the increase in
the number of AJSCC levels; at the same time, with such
increase, the accuracy in the quantization of GSR signal is
improved and the MSE of the GSR signal reduces. From
the curves, we can determine the optimal number of levels
in AJSCC that minimizes the sum MSE, which is a large
number and hence can be realized via Design 2. We notice that
the optimal number of levels depends on channel conditions,
source distribution, and transceiver specifications. We can
also observe that the sampling rate of 8.192 MHz achieves
better MSE performance compared with the sampling rate of
500 kHz, under the same simulation assumptions. Therefore,
in the following simulation evaluations of indoor and outdoor
channels, only 8.192 MHz sampling rate is evaluated.
Performance under Indoor and Outdoor Fading Channels with
Doppler: The results of MSE vs. the number of parallel
lines in AJSCC for indoor and outdoor fading channels (with
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Fig. 6: Mean Square Error (MSE) vs. number of parallel lines in AJSCC with digital receiver by wireless link simulation, for (a) AWGN channel with CSNR
equaling 0 dB, based on digital receiver of 8.192 MHz sampling rate and 8192 FFT size; (b) AWGN channel with CSNR equaling 0 dB, based on digital
receiver of 500 kHz sampling rate and 5000 FFT size; (c) Flat fading channel with zero Doppler and CSNR equaling 0 dB, based on digital receiver of
8.192 MHz sampling rate and 8192 FFT size.
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Fig. 7: Mean Square Error (MSE) vs. number of parallel lines in AJSCC for (a) indoor channel with 5 Hz Doppler and CSNR equaling 0 dB; (b) Outdoor
channel with 20 Hz Doppler and CSNR equaling 0 dB; (c) Outdoor channel with 20 Hz Doppler and CSNR equaling 10 dB. The digital receivers evaluated
are all at 8.192 MHz sampling rate and 8192 FFT size, and results are obtained by wireless link simulation.
same channel models as before) are evaluated. All the digital
receivers have 8.192 MHz sampling rate and 8192 FFT size.
The result for indoor channel with 5 Hz Doppler and 0 dB
CSNR is depicted in Fig. 7a, and the result for outdoor channel
with 20 Hz Doppler and 0 dB CSNR is depicted in Fig. 7b.
With higher CSNR of 10 dB, the result of outdoor channel
with 20 Hz Doppler is depicted in Fig. 7c. The result of
indoor channel with 10 dB CSNR is almost the same to the
result of 10 dB CSNR of outdoor channel, hence it is not
depicted. From these results, we can observe similar trade-
off in MSE of the two source signals for different channel
conditions and receiver configurations. These results indicate
the optimal number of AJSCC levels for each of the channel
conditions simulated. We note that such number varies with
channel conditions and transceiver parameters.
IV. CONCLUSIONS
We presented a new type of wireless biosensing platform
to measure molecular biomarkers and physiological signals
concurrently, and demonstrated the feasibility of constructing
this wireless biosensor. We discussed and compared two
designs for the AJSCC encoding circuits. The second design
provides a much higher flexibility in controlling the number of
AJSCC levels and also achieves better performance compared
with the first design. The presented biosensor system has
been evaluated via both hardware experiments as well as
wireless link simulations. Future work will include developing
a classifier on the digital receiver to classify the cells based on
impedance pulse signals so as to estimate multiple biomarker
concentrations.
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